Small,
Journal Year:
2024,
Volume and Issue:
20(45)
Published: July 25, 2024
Abstract
Immune
checkpoint
inhibitors
(ICIs)
offer
promise
in
breaking
through
the
treatment
and
survival
dilemma
of
triple‐negative
breast
cancer
(TNBC),
yet
only
immunomodulatory
subtype
≈5%
TNBC
patients
respond
as
monotherapy
due
to
lack
effector
immune
cells
(internal
problem)
physical
barrier
(external
limitation)
formed
by
cancer‐associated
fibroblasts
(CAFs).
A
hydrogel
drug‐delivery
platform,
ALG@TBP‐2/Pt(0)/nintedanib
(ALG@TPN),
is
designed
induce
strong
functions
dual
elimination
internal
external
tumor
microenvironment
(TME).
Activated
white
light,
type
I
II
photodynamic
therapy
(PDT),
TBP‐2
generates
large
amounts
reactive
oxygen
species
(ROS)
intracellularly,
oxidizing
mitochondrial
DNA
(mtDNA).
The
unique
catalase
activity
Pt(0)
converts
endogenous
H
2
O
,
reducing
anoxia‐limiting
PDT
enhancing
ROS
generation
efficacy.
Abundant
can
oxidize
cytotoxic
Pt(II),
damaging
nuclear
(nDNA).
Dual
damage
mtDNA
nDNA
might
bi‐directionally
activate
cGAS/STING
pathway
enhance
cell
response.
Besides,
nintedanib
demonstrates
a
significant
inhibitory
effect
on
CAFs,
weakening
deepening
infiltration.
Overall,
study
provides
self‐oxygenating
with
“PDT/chemotherapy/anti‐CAFs”
effect,
triggering
reshape
TME.
Both
interventions
increase
anti‐TNBC
responses.
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: Oct. 13, 2023
Cancer-associated
fibroblasts
(CAFs)
are
a
heterogeneous
cell
population
that
plays
crucial
role
in
remodeling
the
tumor
microenvironment
(TME).
Here,
through
integrated
analysis
of
spatial
and
single-cell
transcriptomics
data
across
six
common
cancer
types,
we
identified
four
distinct
functional
subgroups
CAFs
described
their
distribution
characteristics.
Additionally,
RNA
sequencing
(scRNA-seq)
from
three
additional
types
two
newly
generated
scRNA-seq
datasets
rare
namely
epithelial-myoepithelial
carcinoma
(EMC)
mucoepidermoid
(MEC),
expanded
our
understanding
CAF
heterogeneity.
Cell-cell
interaction
conducted
within
context
highlighted
pivotal
roles
matrix
(mCAFs)
angiogenesis
inflammatory
(iCAFs)
shaping
immunosuppressive
microenvironment.
In
patients
with
breast
(BRCA)
undergoing
anti-PD-1
immunotherapy,
iCAFs
demonstrated
heightened
capacity
facilitating
proliferation,
promoting
epithelial-mesenchymal
transition
(EMT),
contributing
to
establishment
an
Furthermore,
scoring
system
based
on
showed
significant
correlation
immune
therapy
response
melanoma
patients.
Lastly,
provided
web
interface
(
https://chenxisd.shinyapps.io/pancaf/
)
for
research
community
investigate
pan-cancer.
The Innovation,
Journal Year:
2023,
Volume and Issue:
4(6), P. 100503 - 100503
Published: Aug. 29, 2023
•Insights
into
the
intricate
facets
of
immune
microenvironment
hold
key
to
pioneering
clinical
strategies
in
combatting
bacterial
infections.•The
design
principles
for
antimicrobial
biomaterials
vary
depending
on
at
different
stages
infection.•Immunomodulatory
display
robust
efficacy
and
vaccine
attributes
animals
trials,
promising
intractable
infections.
Bacterial
infectious
diseases
are
one
leading
causes
death
worldwide.
Even
with
use
multiple
antibiotic
treatment
strategies,
4.95
million
people
died
from
drug-resistant
infections
2019.
By
2050,
number
deaths
will
reach
10
annually.
The
increasing
mortality
may
be
partly
due
heterogeneity
infection
microenvironment,
such
as
bacteria,
biofilms,
persister
cells,
intracellular
small
colony
variants.
In
addition,
complexity
makes
direct
activity
unsatisfactory
long-term
chronic
attributed
failing
modulate
active
action
cells.
Therefore,
there
is
an
urgent
need
effective
alternatives
treat
Accordingly,
development
immunomodulatory
has
recently
received
considerable
interest;
however,
a
comprehensive
review
their
research
progress
lacking.
this
review,
we
focus
mainly
future
perspectives
used
infection.
First,
describe
characteristics
acute
phases
Then,
highlight
corresponding
advantages
disadvantages.
Moreover,
discuss
biomaterial-mediated
vaccines'
potential
applications
challenges
activating
innate
adaptive
memory.
This
serve
reference
studies
develop
next-generation
accelerate
translation
practice.
Cancer Letters,
Journal Year:
2024,
Volume and Issue:
591, P. 216859 - 216859
Published: April 13, 2024
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
a
solid
organ
malignancy
with
high
mortality
rate.
Statistics
indicate
that
its
incidence
has
been
increasing
as
well
the
associated
deaths.
Most
patients
PDAC
show
poor
response
to
therapies
making
clinical
management
of
this
cancer
difficult.
Stromal
cells
in
tumor
microenvironment
(TME)
contribute
development
resistance
therapy
cells.
Cancer-associated
fibroblasts
(CAFs),
most
prevalent
stromal
TME,
promote
desmoplastic
response,
produce
extracellular
matrix
proteins
and
cytokines,
directly
influence
biological
behavior
These
multifaceted
effects
make
it
difficult
eradicate
from
body.
As
result,
CAF-targeting
synergistic
therapeutic
strategies
have
gained
attention
recent
years.
However,
due
substantial
heterogeneity
CAF
origin,
definition,
function,
plasticity,
majority
available
approaches
are
not
effective,
some
cases,
they
exacerbate
disease
progression.
This
review
primarily
elucidates
on
effect
CAFs
efficiency
various
treatment
modalities,
including
chemotherapy,
radiotherapy,
immunotherapy,
targeted
therapy.
Strategies
for
targeting
also
discussed.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(12)
Published: Jan. 16, 2024
Abstract
In
South
and
Southeast
Asia,
the
habit
of
chewing
betel
nuts
is
prevalent,
which
leads
to
oral
submucous
fibrosis
(OSF).
OSF
a
well‐established
precancerous
lesion,
portion
cases
eventually
progress
squamous
cell
carcinoma
(OSCC).
However,
specific
molecular
mechanisms
underlying
malignant
transformation
OSCC
from
are
poorly
understood.
this
study,
leading‐edge
techniques
Spatial
Transcriptomics
(ST)
Metabolomics
(SM)
integrated
obtain
spatial
location
information
cancer
cells,
fibroblasts,
immune
as
well
transcriptomic
metabolomic
landscapes
in
OSF‐derived
tissues.
This
work
reveals
for
first
time
that
some
cells
undergo
partial
epithelial–mesenchymal
transition
(pEMT)
within
situ
(ISC)
region,
acquiring
fibroblast‐like
phenotypes
participating
collagen
deposition.
Complex
interactions
among
epithelial
tumor
microenvironment
demonstrated.
Most
importantly,
significant
metabolic
reprogramming
OSCC,
including
abnormal
polyamine
metabolism,
potentially
playing
pivotal
role
promoting
tumorigenesis
evasion
discovered.
The
ST
SM
data
study
shed
new
light
on
deciphering
OSCC.
also
offers
invaluable
clues
prevention
treatment
Journal of Hematology & Oncology,
Journal Year:
2025,
Volume and Issue:
18(1)
Published: Jan. 13, 2025
The
tumor
microenvironment
(TME)
is
integral
to
cancer
progression,
impacting
metastasis
and
treatment
response.
It
consists
of
diverse
cell
types,
extracellular
matrix
components,
signaling
molecules
that
interact
promote
growth
therapeutic
resistance.
Elucidating
the
intricate
interactions
between
cells
TME
crucial
in
understanding
progression
challenges.
A
critical
process
induced
by
epithelial-mesenchymal
transition
(EMT),
wherein
epithelial
acquire
mesenchymal
traits,
which
enhance
their
motility
invasiveness
progression.
By
targeting
various
components
TME,
novel
investigational
strategies
aim
disrupt
TME's
contribution
EMT,
thereby
improving
efficacy,
addressing
resistance,
offering
a
nuanced
approach
therapy.
This
review
scrutinizes
key
players
emphasizing
avenues
therapeutically
components.
Moreover,
article
discusses
implications
for
resistance
mechanisms
highlights
current
toward
modulation
along
with
potential
caveats.
International Journal of Nanomedicine,
Journal Year:
2025,
Volume and Issue:
Volume 20, P. 483 - 503
Published: Jan. 1, 2025
Abstract:
Cancer-associated
fibroblasts
(CAFs)
are
a
heterogeneous
population
of
non-malignant
cells
that
play
crucial
role
in
the
tumor
microenvironment,
increasingly
recognized
as
key
contributors
to
cancer
progression,
metastasis,
and
treatment
resistance.
So,
targeting
CAFs
has
always
been
considered
an
important
part
immunotherapy.
However,
improve
efficacy
therapy
is
currently
major
challenge.
Nanomaterials
show
their
unique
advantages
whole
process.
At
present,
nanomaterials
have
achieved
significant
accomplishments
medical
applications,
particularly
field
cancer-targeted
therapy,
showing
enormous
potential.
It
confirmed
can
not
only
directly
target
CAFs,
but
also
interact
with
microenvironment
(TME)
immune
affect
tumorigenesis.
As
for
treatment,
could
enhance
therapeutic
effect
many
ways.
Therefore,
this
review,
we
first
summarized
current
understanding
complex
interactions
between
TME,
cells,
cells.
Next,
discussed
common
modern
medicine
respective
impacts
on
tumors.
Finally,
focus
application
nano
drug
delivery
system
therapy.
Keywords:
cancer-associated
fibroblasts,
delivery,
nanomedicine,
immunotherapy